Article
Author(s):
The National Association for Continence (NAFC) is calling for stricter health care standards for patients with pelvic floor dysfunction, including incontinence and prolapse in women.
NIAGARA: ctDNA analysis highlights durvalumab’s impact in MIBC
Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
Mixed results reported for nivolumab/ipilimumab in cisplatin-ineligible mUC
Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25
Adjuvant pembrolizumab continues to show DFS, OS benefits for ccRCC at 5-year assessment
EFS benefit is seen with sasanlimab in CIS and T1 NMIBC
Nivolumab/ipilimumab continues to show improved survival, durable response in aRCC
EV plus pembrolizumab doubles CR rate vs chemotherapy in la/mUC